First Translational Study Call Clinical Research Unit (CRU) at Experimental and Clinical Research Center (ECRC)

Back

We are calling for applications for pilot (proof-of-concept) studies to be conducted in the ECRC-CRU. All MDC, Charité and ECRC scientists are eligible to submit applications. Application deadline is on 1 February 2021.

Eligibility

All MDC, Charité and ECRC basic and clinician scientists are eligible to apply for funding. Projects that make use of the research environment of Campus Berlin-Buch will be prioritized.

Project requirements

The goal of this call is to establish new collaborations between basic and clinician scientists and the ECRC-CRU in order to conduct clinical proof-of-concept studies. A selected project will be supported with up to 50,000 EUR for consumables and will receive full support from the CRU study team (study administration, obtaining ethics approval). Projects may last up to 24 months.

Essential evaluation criteria

Novel mechanistic research question
Pre-clinical evidence with translational potential
Unmet medical need
Clinical partner with access to patients to be investigated
Clinical study will be conducted in the ECRC-CRU
Feasibility of the study

Selection procedure

The ECRC-CRU Board will select 1-2 projects in a three-stage process. Decisions will be made based on scientific merit, support of the translational mission of the ECRC and feasibility of the study. In the first stage, we ask you to submit a short proposal primarily covering translational potential, unmet medical need and aims and objectives for a clinical study. In the second stage, you will be asked to give a five-minute flash talk pitching your idea. This talk will be held virtually in front of the board and all other selected applicants. In the third stage, we will assist you with refining your idea and shaping a feasible study design. Our aim is to conduct this study within 24 months.